Excelling in Science (Blog)

A blog dedicated to bringing research in the rapidly advancing cell therapy field straight to your newsfeed in an easily digestible way. This blog will also delve into some of the most complicated and frequently asked (but not so frequently answered) scientific questions regarding cellular starting material.

 
A Case of Biological Identity Theft Offers Vital Clue to Solving MS

A Case of Biological Identity Theft Offers Vital Clue to Solving MS

A case of immune cell identity theft gave German scientists

Efficient Isolation of Antigen-Specific B Cells

Efficient Isolation of Antigen-Specific B Cells

Scientists at Scripps Research Center in La Jolla are working

High Precision Remote-Controlled Cancer Immunotherapy

High Precision Remote-Controlled Cancer Immunotherapy

Researchers at UCSD and Memorial Sloan Kettering Cancer Center cite

Excellos NK Cells Aid Discovery of Key Cancer Killing Target

Excellos NK Cells Aid Discovery of Key Cancer Killing Target

A recent publication in Nature Communications cites using Excellos sourced

Healthy Donor Cells Outperform Patient Cells in Cancer Therapy

Healthy Donor Cells Outperform Patient Cells in Cancer Therapy

A new study has shown CAR-T cells derived from healthy

Musings on Supply Chain & Logistics for Cell Therapies

Musings on Supply Chain & Logistics for Cell Therapies

Where the Cell Therapy industry is facing an ever-growing complexity

Building Solid Foundations for Successful Cell Therapies

Building Solid Foundations for Successful Cell Therapies

Raw material experts Dr. David Wellis and Dr. Robert Tressler

Part 2: High-Fidelity Donor Characterization and Successful Cell Therapy

Part 2: High-Fidelity Donor Characterization and Successful Cell Therapy

Next-level characterization of donor immune cells can be used as

Part 1: High-Fidelity Donor Characterization and Successful Cell Therapy

Part 1: High-Fidelity Donor Characterization and Successful Cell Therapy

Donors play an important role in how well patients respond

TIL Therapy Shows Promise for Treating Metastatic Lung Cancer

TIL Therapy Shows Promise for Treating Metastatic Lung Cancer

Scientists at the H. Lee Moffitt Cancer Center in Florida

Excellos T Cells Aid Evaluation of Anti-PD-1 Cancer Treatment

Excellos T Cells Aid Evaluation of Anti-PD-1 Cancer Treatment

Scientists at GSK in Waltham, Massachusetts, are using Excellos-sourced starting

And Blast off……Excellos Launches into (Cell Therapy) Space

And Blast off……Excellos Launches into (Cell Therapy) Space

The launch of Excellos now brings scientific and cell manipulation

Excellos Cellular Material Helps Boost T Cell Immunotherapy Development

Excellos Cellular Material Helps Boost T Cell Immunotherapy Development

T cell immunotherapy is a promising and relatively new field